{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:47:45Z","timestamp":1776329265548,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:00:00Z","timestamp":1519948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1245\/s10434-018-6385-x","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T17:07:40Z","timestamp":1520010460000},"page":"1555-1563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The C-Reactive Protein\/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study"],"prefix":"10.1245","volume":"25","author":[{"given":"Shinkichi","family":"Takamori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gouji","family":"Toyokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototsugu","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Kozuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Haratake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaki","family":"Akamine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Seto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuzo","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Takenoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukito","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"issue":"17","key":"6385_CR1","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1158\/1078-0432.CCR-11-2375","volume":"18","author":"M Ladanyi","year":"2012","unstructured":"Ladanyi M, Zauderer MG, Krug LM, et al. New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment. Clin Cancer Res. 2012;18(17):4485\u201390.","journal-title":"Clin Cancer Res"},{"issue":"5\u20136","key":"6385_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/10937404.2016.1193361","volume":"19","author":"P Andujar","year":"2016","unstructured":"Andujar P, Lacourt A, Brochard P, Pairon JC, Jaurand MC, Jean D. Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles. J Toxicol Environ Health B. 2016;19(5\u20136):151\u201372.","journal-title":"J Toxicol Environ Health B"},{"issue":"9","key":"6385_CR3","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1016\/S1470-2045(17)30459-X","volume":"18","author":"M Perrot","year":"2017","unstructured":"Perrot M, Wu L, Wu M, Cho BCJ. Radiotherapy for the treatment of malignant pleural mesothelioma. Lancet Oncol. 2017;18(9):e532\u2013e42.","journal-title":"Lancet Oncol"},{"key":"6385_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.critrevonc.2016.08.011","volume":"107","author":"G Bronte","year":"2016","unstructured":"Bronte G, Incorvaia L, Rizzo S, et al. The resistance related to targeted therapy in malignant pleural mesothelioma: why has not the target been hit yet? Crit Rev Oncol Hematol. 2016;107:20\u201332.","journal-title":"Crit Rev Oncol Hematol."},{"issue":"1","key":"6385_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ccm.2012.12.005","volume":"34","author":"AR Haas","year":"2013","unstructured":"Haas AR, Sterman DH. Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies. Clin Chest Med. 2013;34(1):99\u2013111.","journal-title":"Clin Chest Med"},{"issue":"2","key":"6385_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0169-5002(01)00257-4","volume":"34","author":"GL Ceresoli","year":"2001","unstructured":"Ceresoli GL, Locati LD, Ferreri AJ, et al. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer. 2001;34(2):279\u201387.","journal-title":"Lung Cancer."},{"key":"6385_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.lungcan.2016.05.010","volume":"98","author":"F Shoji","year":"2016","unstructured":"Shoji F, Morodomi Y, Akamine T, et al. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer. Lung Cancer. 2016;98:15\u201321.","journal-title":"Lung Cancer."},{"issue":"5","key":"6385_CR8","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.21873\/anticanres.11625","volume":"37","author":"T Akamine","year":"2017","unstructured":"Akamine T, Toyokawa G, Matsubara T, et al. Significance of the preoperative CONUT score in predicting postoperative disease-free and overall survival in patients with lung adenocarcinoma with obstructive lung disease. Anticancer Res. 2017;37(5):2735\u201342.","journal-title":"Anticancer Res."},{"key":"6385_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002252","author":"Y Nakashima","year":"2017","unstructured":"Nakashima Y, Saeki H, Nakanishi R, et al. (2017) Assessment of sarcopenia as a predictor of poor outcomes after esophagectomy in elderly patients with esophageal cancer. Ann Surg. \n                    https:\/\/doi.org\/10.1097\/SLA.0000000000002252\n                    \n                  .","journal-title":"Ann Surg"},{"issue":"2","key":"6385_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.21873\/anticanres.11372","volume":"37","author":"F Shoji","year":"2017","unstructured":"Shoji F, Haratake N, Akamine T, et al. The preoperative controlling nutritional status score predicts survival after curative surgery in patients with pathological stage I non-small cell lung cancer. Anticancer Res. 2017;37(2):741\u201347.","journal-title":"Anticancer Res."},{"issue":"9","key":"6385_CR11","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.21037\/jtd.2017.07.108","volume":"9","author":"G Toyokawa","year":"2017","unstructured":"Toyokawa G, Kozuma Y, Matsubara T, et al. Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinoma. J Thorac Dis. 2017;9(9):2942\u201351.","journal-title":"J Thorac Dis."},{"issue":"4","key":"6385_CR12","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1016\/j.cllc.2017.01.008","volume":"18","author":"S Takamori","year":"2017","unstructured":"Takamori S, Toyokawa G, Taguchi K, et al. The controlling nutritional status score is a significant independent predictor of poor prognosis in patients with malignant pleural mesothelioma. Clin Lung Cancer. 2017;18(4):e303\u2013e13.","journal-title":"Clin Lung Cancer."},{"issue":"10","key":"6385_CR13","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","volume":"12","author":"SM Crusz","year":"2015","unstructured":"Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015;12(10):584\u201396.","journal-title":"Nat Rev Clin Oncol."},{"issue":"3","key":"6385_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/JTO.0b013e31823f45c1","volume":"7","author":"DJ Pinato","year":"2012","unstructured":"Pinato DJ, Mauri FA, Ramakrishnan R, Wahab L, Lloyd T, Sharma R. Inflammation-based prognostic indices in malignant pleural mesothelioma. J Thorac Oncol. 2012;7(3):587\u201394.","journal-title":"J Thorac Oncol."},{"issue":"23","key":"6385_CR15","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1158\/1078-0432.CCR-10-2245","volume":"16","author":"SC Kao","year":"2010","unstructured":"Kao SC, Pavlakis N, Harvie R, et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res. 2010;16(23):5805\u201313.","journal-title":"Clin Cancer Res."},{"issue":"1","key":"6385_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7861\/clinmedicine.9-1-30","volume":"9","author":"E Fairclough","year":"2009","unstructured":"Fairclough E, Cairns E, Hamilton J, Kelly C. Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein\/albumin ratio as a predictor of patient outcome. Clin Med. 2009;9(1):30\u201333.","journal-title":"Clin Med."},{"issue":"3","key":"6385_CR17","doi-asserted-by":"publisher","first-page":"e59321","DOI":"10.1371\/journal.pone.0059321","volume":"8","author":"OT Ranzani","year":"2013","unstructured":"Ranzani OT, Zampieri FG, Forte DN, Azevedo LC, Park M. C-reactive protein\/albumin ratio predicts 90-day mortality of septic patients. PloS One. 2013;8(3):e59321.","journal-title":"PloS One."},{"issue":"10","key":"6385_CR18","first-page":"5797","volume":"37","author":"S Ide","year":"2017","unstructured":"Ide S, Toiyama Y, Okugawa Y, et al. Clinical significance of C-reactive protein-to-albumin ratio with rectal cancer patient undergoing chemoradiotherapy followed by surgery. Anticancer Res. 2017;37(10):5797\u2013804.","journal-title":"Anticancer Res."},{"issue":"12","key":"6385_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/dox107","volume":"30","author":"Y Otowa","year":"2017","unstructured":"Otowa Y, Nakamura T, Yamamoto M, et al. C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II\/III esophageal squamous cell cancer. Dis Esophagus. 2017;30(12):1\u20135.","journal-title":"Dis Esophagus."},{"key":"6385_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2017.08.016","author":"K Arima","year":"2017","unstructured":"Arima K, Yamashita YI, Hashimoto D, et al. (2017) Clinical usefulness of postoperative C-reactive protein\/albumin ratio in pancreatic ductal adenocarcinoma. Am J Surg. \n                    https:\/\/doi.org\/10.1016\/j.amjsurg.2017.08.016\n                    \n                  .","journal-title":"Am J Surg"},{"issue":"1","key":"6385_CR21","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1038\/s41598-017-03153-6","volume":"7","author":"J Hang","year":"2017","unstructured":"Hang J, Xue P, Yang H, et al. Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients. Sci Rep. 2017;7(1):2993.","journal-title":"Sci Rep."},{"issue":"19","key":"6385_CR22","doi-asserted-by":"publisher","first-page":"e6848","DOI":"10.1097\/MD.0000000000006848","volume":"96","author":"YW Koh","year":"2017","unstructured":"Koh YW, Lee HW. Prognostic impact of C-reactive protein\/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy. Medicine. 2017;96(19):e6848.","journal-title":"Medicine."},{"issue":"1","key":"6385_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12885-017-3220-x","volume":"17","author":"Y Liu","year":"2017","unstructured":"Liu Y, Chen S, Zheng C, et al. The prognostic value of the preoperative c-reactive protein\/albumin ratio in ovarian cancer. BMC Cancer. 2017;17(1):285.","journal-title":"BMC Cancer."},{"issue":"2","key":"6385_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","volume":"11","author":"F Galateau-Salle","year":"2016","unstructured":"Galateau-Salle F, Churg A, Roggli V, Travis WD. The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification. J Thorac Oncol. 2016;11(2):142\u201354.","journal-title":"J Thorac Oncol."},{"issue":"1","key":"6385_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/carcin\/bgu227","volume":"36","author":"F Baumann","year":"2015","unstructured":"Baumann F, Flores E, Napolitano A, et al. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 2015;36(1):76\u201381.","journal-title":"Carcinogenesis."},{"issue":"4","key":"6385_CR26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2307\/2530120","volume":"35","author":"RL Prentice","year":"1979","unstructured":"Prentice RL, Marek P. A qualitative discrepancy between censored data rank tests. Biometrics. 1979;35(4):861\u201367.","journal-title":"Biometrics."},{"issue":"2","key":"6385_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.clim.2005.08.004","volume":"117","author":"L Marnell","year":"2005","unstructured":"Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol. 2005;117(2):104\u201311.","journal-title":"Clin Immunol."},{"issue":"6","key":"6385_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448\u201354.","journal-title":"N Engl J Med."},{"key":"6385_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1477-7819-8-85","volume":"8","author":"O Kemik","year":"2010","unstructured":"Kemik O, Sumer A, Kemik AS, et al. The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer. World J Surg Oncol. 2010;8:85.","journal-title":"World J Surg Oncol."},{"issue":"8","key":"6385_CR30","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3748\/wjg.v10.i8.1115","volume":"10","author":"N Ilhan","year":"2004","unstructured":"Ilhan N, Ilhan N, Ilhan Y, Akbulut H, Kucuksu M. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J Gastroenterol. 2004;10(8):1115\u201320.","journal-title":"World J Gastroenterol."},{"issue":"2","key":"6385_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","volume":"15","author":"S Grivennikov","year":"2009","unstructured":"Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15(2):103\u201313.","journal-title":"Cancer Cell."},{"issue":"12","key":"6385_CR32","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1172\/JCI32533","volume":"117","author":"P Sansone","year":"2007","unstructured":"Sansone P, Storci G, Tavolari S, et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest. 2007;117(12):3988\u20134002.","journal-title":"J Clin Invest."},{"issue":"5","key":"6385_CR33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/1940-6207.CAPR-15-0347","volume":"9","author":"Y Kadariya","year":"2016","unstructured":"Kadariya Y, Menges CW, Talarchek J, et al. Inflammation-Related IL1beta\/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma. Cancer Prev Res. 2016;9(5):406\u201314.","journal-title":"Cancer Prev Res."},{"issue":"12","key":"6385_CR34","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s00432-013-1523-0","volume":"139","author":"ZH Yao","year":"2013","unstructured":"Yao ZH, Tian GY, Wan YY, et al. Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma. J Cancer Res Clin Oncol. 2013;139(12):2117\u201323.","journal-title":"J Cancer Res Clin Oncol."},{"issue":"7","key":"6385_CR35","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1007\/s13277-014-1938-5","volume":"35","author":"ZH Yao","year":"2014","unstructured":"Yao ZH, Tian GY, Yang SX, et al. Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma. Tumour Biol Oncodev Biol Med. 2014;35(7):6839\u201345.","journal-title":"Tumour Biol Oncodev Biol Med."},{"issue":"4","key":"6385_CR36","first-page":"516","volume":"1","author":"A Linton","year":"2012","unstructured":"Linton A, van Zandwijk N, Reid G, Clarke S, Cao C, Kao S. Inflammation in malignant mesothelioma\u2014friend or foe? Ann Cardiothorac Surg. 2012;1(4):516\u201322.","journal-title":"Ann Cardiothorac Surg."},{"issue":"1","key":"6385_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","volume":"16","author":"D Curran","year":"1998","unstructured":"Curran D, Sahmoud T, Therasse P, van Meerbeeck J, Postmus PE, Giaccone G. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol. 1998;16(1):145\u201352.","journal-title":"J Clin Oncol."},{"issue":"2","key":"6385_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jtho.2015.10.003","volume":"11","author":"A Bille","year":"2016","unstructured":"Bille A, Krug LM, Woo KM, Rusch VW, Zauderer MG. Contemporary analysis of prognostic factors in patients with unresectable malignant pleural mesothelioma. J Thorac Oncol. 2016;11(2):249\u201355.","journal-title":"J Thorac Oncol."},{"issue":"4","key":"6385_CR39","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0022-5223(96)70342-2","volume":"111","author":"VW Rusch","year":"1996","unstructured":"Rusch VW, Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 1996;111(4):815-25; discussion 25\u20136.","journal-title":"J Thorac Cardiovasc Surg."},{"issue":"2","key":"6385_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/bjc.2014.312","volume":"111","author":"GL Ceresoli","year":"2014","unstructured":"Ceresoli GL, Grosso F, Zucali PA, et al. Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey. Br J Cancer. 2014;111(2):220\u201326.","journal-title":"Br J Cancer."},{"issue":"1","key":"6385_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","volume":"117","author":"DJ Sugarbaker","year":"1999","unstructured":"Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999;117(1):54\u201363; discussion 63-5.","journal-title":"J Thorac Cardiovasc Surg."},{"issue":"6","key":"6385_CR42","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0003-4975(03)00010-9","volume":"75","author":"JH Schouwink","year":"2003","unstructured":"Schouwink JH, Kool LS, Rutgers EJ, et al. The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma. Ann Thorac Surg. 2003;75(6):1715\u20138; discussion 18\u20139.","journal-title":"Ann Thorac Surg."},{"issue":"4","key":"6385_CR43","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2214\/ajr.172.4.10587144","volume":"172","author":"RT Heelan","year":"1999","unstructured":"Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol. 1999;172(4):1039\u201347.","journal-title":"AJR Am J Roentgenol."},{"issue":"1","key":"6385_CR44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.lungcan.2015.07.014","volume":"90","author":"T Yamagishi","year":"2015","unstructured":"Yamagishi T, Fujimoto N, Nishi H, et al. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma. Lung Cancer. 2015;90(1):111\u201317.","journal-title":"Lung Cancer."},{"issue":"11","key":"6385_CR45","first-page":"1898","volume":"7","author":"T Tagawa","year":"2015","unstructured":"Tagawa T, Anraku M, Morodomi Y, et al. Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy. J Thorac Dis. 2015;7(11):1898\u2013906.","journal-title":"J Thorac Dis."},{"issue":"11","key":"6385_CR46","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1097\/JTO.0b013e31822a3740","volume":"6","author":"SC Kao","year":"2011","unstructured":"Kao SC, Klebe S, Henderson DW, et al. Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy. J Thorac Oncol. 2011;6(11):1923\u201329.","journal-title":"J Thorac Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6385-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6385-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6385-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T00:10:24Z","timestamp":1551485424000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6385-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,2]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["6385"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6385-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,2]]},"assertion":[{"value":"28 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}